← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Agennix, Inc.
Houston, TX
$7,110,156
Total funding
10
Grants
Funding over time
peak $2.2M · FY2005–09$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$7,110,156 · 10
By mechanism
R44$5,761,454 · 4
R43$681,182 · 4
R42$551,720 · 1
R41$115,800 · 1
Investigators at Agennix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Treatment of Sepsis with Talactoferrin$1,641,430
R44 · FY2008 · GM
Treatment of Sepsis with Talactoferrin$820,614
R44 · FY2009 · GM
Safety and efficacy of rh-Lactoferrin in Diabetic Ulcers$750,005
R44 · FY2004 · AR
Phase II Clinical Trial of Lactoferrin in Asthma$749,920
R44 · FY2005 · AI
Lactoferrin Enhances Growth and Reduces Nosocomial Infection in Preterm Infants$571,731
R44 · FY2009 · HD
Treatment of Sepsis with Talactoferrin$570,399
R44 · FY2007 · GM
Lactoferrin Enhances Growth and Reduces Nosocomial Infection in Preterm Infants$557,320
R44 · FY2008 · HD
Recombinant human lactoferrin to treat oral mucositis$349,929
R43 · FY2004 · DE
Therapy for gastrointestinal disorders$277,017
R42 · FY2002 · DK
Therapy for gastrointestinal disorders$274,703
R42 · FY2001 · DK
Treatment of Sepsis using Recombinant Human Lactoferrin$130,595
R43 · FY2006 · GM
Recombinant Lactoferrin and Necrotizing Enterocolitis$115,800
R41 · FY2004 · HD
POTENTIAL THERAPEUTIC USE OF LACTOFERRIN IN ASTHMA$100,733
R43 · FY2000 · AI
Safety and efficacy of rh-Lactoferrin in Diabetic Ulcers$100,035
R44 · FY2003 · AR
Lactoferrin in Primate and Mouse Models of Asthma$99,925
R43 · FY2004 · AI